GLP-2TZ    Tablets 25

GLP-2TZ Tablets 25

$85.99

GLP-2TZ Tablets

(Tablets come in a smaller 8 oz bottle)

What is GLP-2TZ?
GLP-2TZ is a dual incretin mimetic — it activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action makes it more potent than standard GLP-1 agonists (like semaglutide) for weight loss and metabolic regulation.

What Does It Do?

  • Regulates Appetite & Cravings: Helps you feel full and reduces overeating.
  • Improves Insulin Sensitivity: Lowers blood sugar and supports glycemic control.
  • Supports Fat Loss: Promotes significant reductions in visceral and body fat.
  • Cardiometabolic Health: Supports healthy blood pressure, cholesterol, and liver fat reduction.
  • Neurological Benefits: Stable blood sugar improves energy, mood, and focus.

Why Use GLP-2TZ?
It’s next-gen metabolic biohacking, working on two powerful gut-hormone pathways instead of one. Clinical studies show it is more effective than semaglutide for weight loss and glycemic control.

Key Advantages:

  • 🚀 Dual Pathway Power: Activates GLP-1 & GIP for superior results
  • 🔥 Significant Weight Loss: Up to 20%+ body weight reduction in trials
  • 🩸 Glycemic & Insulin Control: Supports stable blood sugar
  • ❤️ Cardiometabolic Protection: Benefits heart, liver, and vascular health
  • 🧠 Mood & Cognitive Boost: Stable energy, reduced brain fog, improved focus
  • 🌐 Next-Gen Biohacking Molecule: Beyond semaglutide; precision metabolic control

⚠️ Important Notice

This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.

By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.

Your Inquiry Matters

Have a question about our research-only compounds or quality standards? 

Reach out using the form below. Our team responds with compliant guidance for laboratory and analytical inquiries.